| Tue, Nov 24, 2009 | | • | 4 Platform Drugmakers to Invest In
at Motley Fool (Tue, Nov 24)
| | Fri, Nov 20, 2009 | | • | [$$] The Ascending Trend Line Breaks
at RealMoney by TheStreet.com (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | • | Should You Buy It? Alkermes
RealMoney by TheStreet.com (Thu, Nov 19)
| | Wed, Nov 18, 2009 | | • | Good News for Alkermes' Pipeline
Zacks.com (Wed, Nov 18)
| | • | Tuesday's Big Gainers on Heavy Volume
at Seeking Alpha (Wed, Nov 18)
| | Tue, Nov 17, 2009 | | • | [$$] Activity Jumps in Biotech and Drug Firms
at The Wall Street Journal Online (Tue, Nov 17)
| | • | Alkermes Begins Trials for ALKS 33
at Fox Business (Tue, Nov 17)
| | • | Biotech Stocks: Alkermes gains; Cerus, InterMune tumble
at MarketWatch (Tue, Nov 17)
| | • | 4-Star Stocks Poised to Pop: Alkermes
at Motley Fool (Tue, Nov 17)
| | • | Alkermes Initiates Phase 2 Clinical Study of ALKS 33 for the Treatment of Alcohol Dependence
Business Wire (Tue, Nov 17)
| | • | Alkermes upgraded by Leerink Swann
Briefing.com (Tue, Nov 17)
| | • | BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
at Seeking Alpha (Tue, Nov 17)
| | Mon, Nov 16, 2009 | | • | [$$] Sonic Solutions, Nabi and Bristow Advance
at The Wall Street Journal Online (Mon, Nov 16)
| | • | Alkermes' Vivitrol succeeds in opiate study
AP (Mon, Nov 16)
| | • | UPDATE - Alkermes says drug meets main goal of late-stage trial
at Reuters (Mon, Nov 16)
| | • | Alkermes Announces Positive Results from Phase 3 Clinical Study of Naltrexone for Extended-Release Injectable Suspension for the Treatment of Opioid Dependence
Business Wire (Mon, Nov 16)
| | Thu, Nov 12, 2009 | | • | Mannkind Draws Bet on Big Upside Move
at TheStreet.com (Thu, Nov 12)
| | Wed, Nov 11, 2009 | | • | Bulls Buy Oshkosh, Alkermes: Options Recap
at TheStreet.com (Wed, Nov 11)
| | • | Wednesday Options Recap
at Seeking Alpha (Wed, Nov 11)
| | • | ALKERMES INC Financials
EDGAR Online Financials (Wed, Nov 11)
|
Add ALKS News to My Yahoo!:
 
| |
|
0.18% Nasdaq 
0.42%
Headlines
